ATC
CRL icon

Argent Trust Co’s Charles River Laboratories CRL Stock Holding History

Argent Trust Co’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,441
Closed -$308K – 500
2022
Q2 		$308K Sell
1,441
-10
-0.7% -$2.44K 0.02% 420
2022
Q1 		$412K Buy
1,451
+185
+15% +$57K 0.03% 387
2021
Q4 		$477K Buy
1,266
+30
+2% +$11.7K 0.03% 366
2021
Q3 		$510K Buy
1,236
+113
+10% +$46.9K 0.03% 342
2021
Q2 		$416K Buy
1,123
+34
+3% +$11.4K 0.03% 377
2021
Q1 		$315K Buy
+1,089
New +$303K 0.02% 414

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Argent Trust Co's CRL Position: Q3 2022 in Review

Argent Trust Co sold out of Charles River Laboratories (CRL) in Q3 2022, closing a stake of 1,441 shares — an estimated $308K sold.

Argent Trust Co first reported a position in CRL in Q1 2021 and held it in 6 quarters. The position peaked at $510K in Q3 2021. 583 funds tracked by Wall St. Rank hold CRL as of Q3 2022.

  • Argent Trust Co reported no remaining Charles River Laboratories position as of Q3 2022 after selling out during the quarter.
  • Argent Trust Co sold 1,441 Charles River Laboratories shares in Q3 2022, an estimated $308K.
  • Argent Trust Co first reported a position in Charles River Laboratories in Q1 2021 and held it in 6 quarters.
  • Argent Trust Co's Charles River Laboratories position peaked at $510K in Q3 2021.
  • 583 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2022.

Based on Argent Trust Co's 13F filing for Q3 2022, filed 10 Nov 2022.